Clinaxel

Oncovet Clinical Research (O.C.R.) is an innovative Contract Research Organization specialized in the conception and management of clinical trials on Dogs & Cats models with naturally occurring pathologies for efficacy assessment of drug candidates for Human Health. O.C.R. innovative offer is at the forefront of ethics of research involving animals since Dogs & Cats included in clinical trials benefit from new therapies developed for Human. O.C.R. main therapeutic fields are Oncology, Inflammation, Cardiology & Neurology. O.C.R. proposes to support Pharma & Biotech in furthering their drug development programs (in preclinical & clinical phases) by getting key additional scientific information in high level predictive models of human diseases (Dogs & Cats). O.C.R. specificity is to combine recognized experts in veterinary medicine, a multicenter recruitment network, a state of the art technical platform (histopathology lab. & advanced imaging devices) and high quality standards, applied to drug development for Human Health.